Uncertainty on the effectiveness and safety of rivaroxaban in premenopausal women with atrial fibrillation: empirical evidence needed
Crossref DOI link: https://doi.org/10.1186/s12872-017-0692-1
Published Online: 2017-10-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rolden, Herbert J. A.
Maas, Angela H. E. M.
van der Wilt, Gert Jan
Grutters, Janneke P. C.
Funding for this research was provided by:
ZonMw (113105004)